(Q44992734)

English

Tacrolimus as monotherapy or combined with minidose methotrexate for graft-versus-host disease prophylaxis after allogeneic peripheral blood stem cell transplantation: long-term outcomes

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Tacrolimus as monotherapy or combined with minidose methotrexate for graft-versus-host disease prophylaxis after allogeneic peripheral blood stem cell transplantation: long-term outcomes (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

1 reference

based on heuristic

inferred from title

author name string

Uberti JP

1

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Ayash L

2

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Braun T

3

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Reynolds C

4

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Silver S

5

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Ratanatharathorn V

6

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

language of work or name

0 references

publication date

1 September 2004

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

34

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

425-431

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1704594

0 references

Tacrolimus: a new agent for the prevention of graft-versus-host disease in hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704594

21 January 2018

Phase III study comparing tacrolimus (FK506) with cyclosporine for graft-versus-host disease prophylaxis after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704594

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704594

21 January 2018

Estimation of failure probabilities in the presence of competing risks: new representations of old estimators

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704594

21 January 2018

Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704594

21 January 2018

Tacrolimus and minidose methotrexate for prevention of acute graft-versus-host disease after HLA-mismatched marrow or blood stem cell transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704594

21 January 2018

Chronic graft-versus-host disease after allogeneic blood stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704594

21 January 2018

Acute and chronic graft-versus-host disease after allogeneic peripheral-blood stem-cell and bone marrow transplantation: a meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704594

21 January 2018

Tacrolimus and methotrexate for the prophylaxis of acute graft-versus-host disease in allogeneic bone marrow transplantation in patients with hematologic malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704594

7 January 2021

based on heuristic

inferred from DOI database lookup

Tacrolimus vs. cyclosporine immunosuppression: results in advanced-stage disease compared with historical controls treated exclusively with cyclosporine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704594

7 January 2021

based on heuristic

inferred from DOI database lookup

Allogeneic transplantation for advanced leukemia: improved short-term outcome with blood stem cell grafts and tacrolimus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704594

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose therapy followed by autologous hematopoietic stem-cell infusion for patients with multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704594

7 January 2021

based on heuristic

inferred from DOI database lookup

A survey of the prophylaxis and treatment of acute GVHD in Europe: a report of the European Group for Blood and Marrow, Transplantation (EBMT). Chronic Leukaemia Working Party of the EBMT

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704594

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomised, prospective comparison of allogeneic bone marrow and peripheral blood progenitor cell transplantation in the treatment of haematological malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704594

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized trial of bone marrow versus lenograstim-primed blood cell allogeneic transplantation in patients with early-stage leukemia: a report from the Société Française de Greffe de Moelle

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704594

7 January 2021

based on heuristic

inferred from DOI database lookup

Allogeneic blood and bone-marrow stem-cell transplantation in haematological malignant diseases: a randomised trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704594

7 January 2021

based on heuristic

inferred from DOI database lookup

Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704594

7 January 2021

based on heuristic

inferred from DOI database lookup

Chronic graft-versus-host disease after allogeneic blood stem cell transplantation: long-term results of a randomized study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704594

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.BMT.1704594

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44992734&oldid=2060711901"